
Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings
Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 立信会计师事务所(特殊普通合伙)关于天津瑞普生物技术股份有限公司2023年度募集资金存放与使用情况专项报告的鉴证报告 | 2024-03-29 | Chinese | |
| 2023年年度报告 | 2024-03-29 | Chinese | |
| 独立董事2023年度述职报告(郭春林) | 2024-03-29 | Chinese | |
| 2023年年度审计报告 | 2024-03-29 | Chinese | |
| 2023年年度报告披露提示性公告 | 2024-03-29 | Chinese | |
| 2023年度环境、社会及公司治理(ESG)报告 | 2024-03-29 | Chinese |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 35910281 | 立信会计师事务所(特殊普通合伙)关于天津瑞普生物技术股份有限公司2023年度募集资金存放与使用情况专项报告的鉴证报告 | 2024-03-29 | Chinese | ||
| 35910279 | 2023年年度报告 | 2024-03-29 | Chinese | ||
| 35910273 | 独立董事2023年度述职报告(郭春林) | 2024-03-29 | Chinese | ||
| 35910268 | 2023年年度审计报告 | 2024-03-29 | Chinese | ||
| 35910220 | 2023年年度报告披露提示性公告 | 2024-03-29 | Chinese | ||
| 35910212 | 2023年度环境、社会及公司治理(ESG)报告 | 2024-03-29 | Chinese | ||
| 35909999 | 2023年度监事会工作报告 | 2024-03-29 | Chinese | ||
| 35909989 | 关于提请股东大会授权董事会以简易程序向特定对象发行股票的公告 | 2024-03-29 | Chinese | ||
| 35909987 | 2023年度募集资金存放与使用情况专项报告 | 2024-03-29 | Chinese | ||
| 35909979 | 天津瑞普生物技术股份有限公司拟进行股权收购所涉及的保定市收骏科技有限公司股东全部权益价值项目资产评估报告 | 2024-03-29 | Chinese | ||
| 35909975 | 中国银河证券股份有限公司关于天津瑞普生物技术股份有限公司部分募投项目延期的核查意见 | 2024-03-29 | Chinese | ||
| 35909962 | 中国银河证券股份有限公司关于天津瑞普生物技术股份有限公司2023年度内部控制自我评价报告的核查意见 | 2024-03-29 | Chinese | ||
| 35909953 | 2023年度财务决算报告 | 2024-03-29 | Chinese | ||
| 35909945 | 中国银河证券股份有限公司关于天津瑞普生物技术股份有限公司2023年度募集资金年度存放与使用情况专项报告的核查意见 | 2024-03-29 | Chinese | ||
| 35909934 | 关于部分募投项目延期的公告 | 2024-03-29 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Tianjin Ringpu Bio-Technology Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55131/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55131 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55131 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55131 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55131}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tianjin Ringpu Bio-Technology Co.,Ltd. (id: 55131)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.